Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Host Investor Event on March 19, 2026
Mapi Pharma to Present New Safety and Efficacy Data from Glatiramer Acetate Depot Long-Acting Injection Phase II Study in Patients with Primary Progressive Multiple Sclerosis (PPMS) at ACTRIMS Forum 2026 [Yahoo! Finance]
Viatris Appoints Matthew J. Maletta as Chief Legal Officer [Yahoo! Finance]
Viatris Appoints Matthew J. Maletta as Chief Legal Officer
What Are Wall Street Analysts' Target Price for Viatris Stock? [Yahoo! Finance]